Skip to main content
Veda Giri, MD, Oncology, New Haven, CT

VedaGiriMD

Oncology New Haven, CT

Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Professor of Medicine Director, Cancer Genetics and Prevention Program Director, Early Onset Cancer Program Yale Cancer Center and Yale School of Medicine

Dr. Giri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Giri's full profile

Already have an account?

  • Office

    333 Cedar Street
    New Haven, CT 06520

Summary

  • Veda N. Giri, MD is Professor of Medicine at Yale University and is a medical oncologist with specialization in clinical cancer genetics. She serves as Division Chief of Clinical Cancer Genetics for Yale School of Medicine, Director of the Cancer Genetics and Prevention Program, and Director of the Early-Onset Cancer Program at Yale Cancer Center. As leader of Cancer Genetics and Prevention, Dr. Giri leads a comprehensive effort in genetic evaluation for precision medicine, tailored cancer screening, and hereditary cancer assessment across patient populations. She is the Principal Investigator of multiple grant-funded cancer genetic evaluation studies spanning genetic counseling, genetic testing, disparities, behavioral science, and implementation research. As Director of the Early-Onset Cancer Program, Dr. Giri is leading a cutting-edge translational effort to address clinical, research, and psychosocial needs of patients with early-onset cancers. Dr. Giri serves on several national committees including the National Comprehensive Cancer Network, NIH PDQ® Cancer Genetics Editorial Board, and American Society of Clinical Oncology, contributing expertise in cancer genetics at the national level.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1997 - 2000
  • University of Michigan
    University of MichiganInternship, Internal Medicine, 1997 - 1998
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2022 - 2024
  • PA State Medical License
    PA State Medical License 2004 - 2024
  • NJ State Medical License
    NJ State Medical License 2017 - 2023
  • DE State Medical License
    DE State Medical License 2017 - 2019
  • MI State Medical License
    MI State Medical License 1999 - 2006
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Hobart Amory Hare Honor Medical Society Jefferson Medical College, 1996
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Genetic Testing for Inherited Prostate Cancer in Practice: Implications for Genetic Testing, Precision Therapy, and Cascade Testing  
    Colette Hyatt, William K Kelly, Veda N Giri, Leonard G Gomella, Karen E Knudsen, The Prostate

Press Mentions

  • Dr. Veda Giri on Yale Cancer Answers: A Rise in Early Onset Cancers: What Does It Mean?
    Dr. Veda Giri on Yale Cancer Answers: A Rise in Early Onset Cancers: What Does It Mean?October 28th, 2024
  • Video May Aid in Precision Medicine for Prostate Cancer
    Video May Aid in Precision Medicine for Prostate CancerOctober 13th, 2021
  • Veda Giri, MD, on Genetic Testing in Prostate Cancer
    Veda Giri, MD, on Genetic Testing in Prostate CancerOctober 21st, 2020
  • Join now to see all